Genetic tests during pregnancy refer to investigations used to evaluate the probability or presence of certain genetic or chromosomal conditions in the fetus. In practice, they are divided into two major categories: screening tests and diagnostic tests. Screening tests do not establish a diagnosis with certainty, but show whether there is a higher or lower risk for certain conditions. Diagnostic tests directly analyze cells taken from the placenta or the amniotic fluid and can provide a much clearer answer.<\/p>\n\n\n\n
These investigations may be recommended to evaluate certain aneuploidies, such as trisomy 21, trisomy 18, or trisomy 13, but also in more specific contexts, such as suspicion of an inherited genetic disease within the family. What matters is that the choice between the different types of genetic tests during pregnancy is not made in the same standard way for all patients, but according to medical history, maternal age, ultrasound findings, and the results of screening tests already performed.<\/p>\n\n\n\n
What the Main Testing Options During Pregnancy Are<\/strong><\/h2>\n\n\n\nScreening Tests<\/strong><\/h3>\n\n\n\nThe category of genetic tests during pregnancy that function as screening includes first-trimester combined screening, certain second-trimester serum tests, and non-invasive prenatal testing, known as NIPT. Combined screening is usually performed between 10 and 14 weeks and includes a blood test together with ultrasound measurement of nuchal translucency. If the pregnancy is more advanced, second-trimester serum screening may also be considered.<\/p>\n\n\n\n
NIPT is one of the best-known modern options among genetic tests during pregnancy because it analyzes cell-free fetal DNA circulating in the mother\u2019s blood and can be performed from 10 weeks of pregnancy. Its major advantage is that it is non-invasive, but its role must be properly understood: NIPT remains a screening test, not a test that definitively confirms a diagnosis. In other words, a high-risk result must later be discussed in the medical context and, in many cases, confirmed through a diagnostic method.<\/p>\n\n\n\n
Another type of testing, different from fetal screening itself, is parental carrier screening, which can be performed before conception or during pregnancy in order to see whether the parents are carriers of genes associated with certain inherited diseases. In some situations, this very usefully complements the discussion about genetic tests during pregnancy, especially when there is a relevant family history. In this context, genetic counseling before IVF can clarify in advance which investigations are truly useful and what the limitations of each test are.<\/p>\n\n\n\n
Diagnostic Tests<\/strong><\/h3>\n\n\n\nWhen screening indicates a higher risk or when there is an important clinical suspicion, the doctor may recommend diagnostic testing. The best-known methods are chorionic villus sampling, known as CVS, and amniocentesis. CVS is usually performed between 11 weeks and 13 weeks plus 6 days, while amniocentesis is generally recommended after 15 weeks of pregnancy.<\/p>\n\n\n\n
These types of genetic tests during pregnancy are invasive and that is precisely why the indication for them must be individualized. They have a diagnostic role, which means that they can confirm or exclude certain chromosomal or genetic abnormalities with much greater precision. At the same time, because they are invasive procedures, the decision must be made after careful discussion about benefits, limitations, and procedural risks.<\/p>\n\n\n\n\n \n \n\n \n \n \u201cYou deserve to be heard, seen, treated with respect, and supported throughout every stage of life.\u201d <\/h2>\n \n \n ![\"Andreas](\"https:\/\/genesisathens.ro\/wp-content\/uploads\/2025\/10\/Dr.-Andreas-Vythoulkas-150x150.webp\")
\n \n Andreas Vythoulkas<\/p>\n
Specialty Placeholder<\/p>\n <\/div>\n <\/div>\n <\/div>\n\n
\n \n ![\"Ilustra\u021bie](\"https:\/\/genesisathens.ro\/wp-content\/uploads\/2025\/10\/Doctor-Patient-Care.jpg\")
\n <\/div>\n \n \n ![\"Ilustra\u021bie](\"https:\/\/genesisathens.ro\/wp-content\/uploads\/2025\/10\/Expecting-Mother.jpg\")
\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\nWhen Genetic Tests During Pregnancy Are Recommended<\/strong><\/h2>\n\n\n\nNot all patients need the same testing plan. In general, the doctor may recommend genetic tests during pregnancy in several well-defined situations:<\/p>\n\n\n\n
\n- when the results of previous screening suggest a higher risk<\/li>\n\n\n\n
- when ultrasound raises suspicion of a fetal abnormality<\/li>\n\n\n\n
- when there is a family history of genetic disease<\/li>\n\n\n\n
- when there has been a previous pregnancy affected by a genetic or chromosomal abnormality<\/li>\n\n\n\n
- when there are maternal or paternal risk factors that justify further evaluation<\/li>\n<\/ul>\n\n\n\n
It is important to know that advanced maternal age may influence recommendations, but it is not the only criterion. In many cases, the indication for genetic tests during pregnancy appears after correlating several elements: medical history, ultrasound, biochemical results, and the discussion about family history. That is why testing should not be understood as a formality, but as part of a careful medical monitoring process.<\/p>\n\n\n\n
For patients who achieved pregnancy after assisted reproduction treatment, the frequent question arises whether prenatal testing is still necessary. The answer depends on the context. Even if procedures such as aneuploidy screening (PGT-A) or embryo biopsy were used before embryo transfer, these do not automatically replace all pregnancy monitoring recommendations. PGT-A belongs to the preimplantation stage, while genetic tests during pregnancy refer to prenatal monitoring after pregnancy has been achieved.<\/p>\n\n\n\n
How to Choose the Right Investigation Without Confusing Screening and Diagnosis<\/strong><\/h2>\n\n\n\nOne of the most frequent mistakes is to view all genetic tests during pregnancy as having the same medical value. In reality, the difference between \u201crisk estimation\u201d and \u201cdiagnostic confirmation\u201d completely changes the way a result should be interpreted. A low-risk screening result does not absolutely exclude every condition, and a high-risk screening result does not automatically mean there is a certain diagnosis.<\/p>\n\n\n\n
That is why the correct choice begins with a few simple questions: what exactly is being looked for, what can the test show, what can it not show, and what follows after the result. In some cases, the answer is sufficiently covered by screening and ultrasound. In other situations, the doctor may recommend additional investigations or diagnostic testing. What matters is that the decision is made in an informed way, without pressure, and with a clear understanding of the limits of each method.<\/p>\n\n\n\n
Frequently Asked Questions<\/strong><\/h2>\n\n\n\nAre genetic tests during pregnancy mandatory?<\/strong>
No. These investigations are part of prenatal monitoring options and are recommended depending on the clinical context. The decision is made together with the doctor, after you understand the benefits, limitations, and what information each test can provide.<\/p>\n\n\n\nWhat is the difference between NIPT and amniocentesis?<\/strong>
NIPT is a screening test performed from maternal blood and estimates the risk for certain chromosomal abnormalities. Amniocentesis is an invasive diagnostic test, performed after 15 weeks, which can more clearly confirm certain abnormalities.<\/p>\n\n\n\nFrom how many weeks can genetic tests during pregnancy be done?<\/strong>
Some screening tests can be performed starting from around 10 weeks, while CVS is usually carried out between 11 weeks and 13 weeks plus 6 days. Amniocentesis is generally recommended after 15 weeks.<\/p>\n\n\n\nDoes a good screening result exclude every genetic problem?<\/strong>
Not completely. A low-risk result reduces the probability of certain investigated conditions, but it does not exclude all genetic conditions or all fetal development problems.<\/p>\n\n\n\nWhen is amniocentesis recommended?<\/strong>
Amniocentesis may be recommended when there is a high-risk screening result, an ultrasound suspicion, or family or obstetric history that justifies diagnostic testing.<\/p>\n\n\n\nIf the pregnancy was achieved through In Vitro Fertilization, are genetic tests during pregnancy still useful?<\/strong>
Yes, they may still be useful, depending on medical history and the doctor\u2019s recommendation. Preimplantation testing and prenatal monitoring serve different roles and should not be confused.<\/p>\n\n\n\nIs carrier screening the same thing as fetal testing?<\/strong>
No. Carrier screening refers to the parents and shows whether they are carriers of genes associated with certain inherited diseases. Prenatal fetal testing looks for a different type of information and is used at a different stage.<\/p>\n\n\n\nHow should the results be interpreted correctly?<\/strong>
Results should always be interpreted in the clinical context, together with the obstetrician and, when needed, the medical geneticist. An isolated result without correlation with ultrasound and medical history can lead to incorrect conclusions.<\/p>\n\n\n\n\n
The category of genetic tests during pregnancy that function as screening includes first-trimester combined screening, certain second-trimester serum tests, and non-invasive prenatal testing, known as NIPT. Combined screening is usually performed between 10 and 14 weeks and includes a blood test together with ultrasound measurement of nuchal translucency. If the pregnancy is more advanced, second-trimester serum screening may also be considered.<\/p>\n\n\n\n
NIPT is one of the best-known modern options among genetic tests during pregnancy because it analyzes cell-free fetal DNA circulating in the mother\u2019s blood and can be performed from 10 weeks of pregnancy. Its major advantage is that it is non-invasive, but its role must be properly understood: NIPT remains a screening test, not a test that definitively confirms a diagnosis. In other words, a high-risk result must later be discussed in the medical context and, in many cases, confirmed through a diagnostic method.<\/p>\n\n\n\n
Another type of testing, different from fetal screening itself, is parental carrier screening, which can be performed before conception or during pregnancy in order to see whether the parents are carriers of genes associated with certain inherited diseases. In some situations, this very usefully complements the discussion about genetic tests during pregnancy, especially when there is a relevant family history. In this context, genetic counseling before IVF can clarify in advance which investigations are truly useful and what the limitations of each test are.<\/p>\n\n\n\n
Diagnostic Tests<\/strong><\/h3>\n\n\n\nWhen screening indicates a higher risk or when there is an important clinical suspicion, the doctor may recommend diagnostic testing. The best-known methods are chorionic villus sampling, known as CVS, and amniocentesis. CVS is usually performed between 11 weeks and 13 weeks plus 6 days, while amniocentesis is generally recommended after 15 weeks of pregnancy.<\/p>\n\n\n\n
These types of genetic tests during pregnancy are invasive and that is precisely why the indication for them must be individualized. They have a diagnostic role, which means that they can confirm or exclude certain chromosomal or genetic abnormalities with much greater precision. At the same time, because they are invasive procedures, the decision must be made after careful discussion about benefits, limitations, and procedural risks.<\/p>\n\n\n\n\n \n \n\n \n \n \u201cYou deserve to be heard, seen, treated with respect, and supported throughout every stage of life.\u201d <\/h2>\n \n \n \n \n Andreas Vythoulkas<\/p>\n
Specialty Placeholder<\/p>\n <\/div>\n <\/div>\n <\/div>\n\n
\n \n \n <\/div>\n \n \n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\nWhen Genetic Tests During Pregnancy Are Recommended<\/strong><\/h2>\n\n\n\nNot all patients need the same testing plan. In general, the doctor may recommend genetic tests during pregnancy in several well-defined situations:<\/p>\n\n\n\n
\n- when the results of previous screening suggest a higher risk<\/li>\n\n\n\n
- when ultrasound raises suspicion of a fetal abnormality<\/li>\n\n\n\n
- when there is a family history of genetic disease<\/li>\n\n\n\n
- when there has been a previous pregnancy affected by a genetic or chromosomal abnormality<\/li>\n\n\n\n
- when there are maternal or paternal risk factors that justify further evaluation<\/li>\n<\/ul>\n\n\n\n
It is important to know that advanced maternal age may influence recommendations, but it is not the only criterion. In many cases, the indication for genetic tests during pregnancy appears after correlating several elements: medical history, ultrasound, biochemical results, and the discussion about family history. That is why testing should not be understood as a formality, but as part of a careful medical monitoring process.<\/p>\n\n\n\n
For patients who achieved pregnancy after assisted reproduction treatment, the frequent question arises whether prenatal testing is still necessary. The answer depends on the context. Even if procedures such as aneuploidy screening (PGT-A) or embryo biopsy were used before embryo transfer, these do not automatically replace all pregnancy monitoring recommendations. PGT-A belongs to the preimplantation stage, while genetic tests during pregnancy refer to prenatal monitoring after pregnancy has been achieved.<\/p>\n\n\n\n
How to Choose the Right Investigation Without Confusing Screening and Diagnosis<\/strong><\/h2>\n\n\n\nOne of the most frequent mistakes is to view all genetic tests during pregnancy as having the same medical value. In reality, the difference between \u201crisk estimation\u201d and \u201cdiagnostic confirmation\u201d completely changes the way a result should be interpreted. A low-risk screening result does not absolutely exclude every condition, and a high-risk screening result does not automatically mean there is a certain diagnosis.<\/p>\n\n\n\n
That is why the correct choice begins with a few simple questions: what exactly is being looked for, what can the test show, what can it not show, and what follows after the result. In some cases, the answer is sufficiently covered by screening and ultrasound. In other situations, the doctor may recommend additional investigations or diagnostic testing. What matters is that the decision is made in an informed way, without pressure, and with a clear understanding of the limits of each method.<\/p>\n\n\n\n
Frequently Asked Questions<\/strong><\/h2>\n\n\n\nAre genetic tests during pregnancy mandatory?<\/strong>
No. These investigations are part of prenatal monitoring options and are recommended depending on the clinical context. The decision is made together with the doctor, after you understand the benefits, limitations, and what information each test can provide.<\/p>\n\n\n\nWhat is the difference between NIPT and amniocentesis?<\/strong>
NIPT is a screening test performed from maternal blood and estimates the risk for certain chromosomal abnormalities. Amniocentesis is an invasive diagnostic test, performed after 15 weeks, which can more clearly confirm certain abnormalities.<\/p>\n\n\n\nFrom how many weeks can genetic tests during pregnancy be done?<\/strong>
Some screening tests can be performed starting from around 10 weeks, while CVS is usually carried out between 11 weeks and 13 weeks plus 6 days. Amniocentesis is generally recommended after 15 weeks.<\/p>\n\n\n\nDoes a good screening result exclude every genetic problem?<\/strong>
Not completely. A low-risk result reduces the probability of certain investigated conditions, but it does not exclude all genetic conditions or all fetal development problems.<\/p>\n\n\n\nWhen is amniocentesis recommended?<\/strong>
Amniocentesis may be recommended when there is a high-risk screening result, an ultrasound suspicion, or family or obstetric history that justifies diagnostic testing.<\/p>\n\n\n\nIf the pregnancy was achieved through In Vitro Fertilization, are genetic tests during pregnancy still useful?<\/strong>
Yes, they may still be useful, depending on medical history and the doctor\u2019s recommendation. Preimplantation testing and prenatal monitoring serve different roles and should not be confused.<\/p>\n\n\n\nIs carrier screening the same thing as fetal testing?<\/strong>
No. Carrier screening refers to the parents and shows whether they are carriers of genes associated with certain inherited diseases. Prenatal fetal testing looks for a different type of information and is used at a different stage.<\/p>\n\n\n\nHow should the results be interpreted correctly?<\/strong>
Results should always be interpreted in the clinical context, together with the obstetrician and, when needed, the medical geneticist. An isolated result without correlation with ultrasound and medical history can lead to incorrect conclusions.<\/p>\n\n\n\n\n
\n \u201cYou deserve to be heard, seen, treated with respect, and supported throughout every stage of life.\u201d <\/h2>\n \n \n \n \n Andreas Vythoulkas<\/p>\n
Specialty Placeholder<\/p>\n <\/div>\n <\/div>\n <\/div>\n\n
\n \n \n <\/div>\n \n \n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\nWhen Genetic Tests During Pregnancy Are Recommended<\/strong><\/h2>\n\n\n\nNot all patients need the same testing plan. In general, the doctor may recommend genetic tests during pregnancy in several well-defined situations:<\/p>\n\n\n\n
\n- when the results of previous screening suggest a higher risk<\/li>\n\n\n\n
- when ultrasound raises suspicion of a fetal abnormality<\/li>\n\n\n\n
- when there is a family history of genetic disease<\/li>\n\n\n\n
- when there has been a previous pregnancy affected by a genetic or chromosomal abnormality<\/li>\n\n\n\n
- when there are maternal or paternal risk factors that justify further evaluation<\/li>\n<\/ul>\n\n\n\n
It is important to know that advanced maternal age may influence recommendations, but it is not the only criterion. In many cases, the indication for genetic tests during pregnancy appears after correlating several elements: medical history, ultrasound, biochemical results, and the discussion about family history. That is why testing should not be understood as a formality, but as part of a careful medical monitoring process.<\/p>\n\n\n\n
For patients who achieved pregnancy after assisted reproduction treatment, the frequent question arises whether prenatal testing is still necessary. The answer depends on the context. Even if procedures such as aneuploidy screening (PGT-A) or embryo biopsy were used before embryo transfer, these do not automatically replace all pregnancy monitoring recommendations. PGT-A belongs to the preimplantation stage, while genetic tests during pregnancy refer to prenatal monitoring after pregnancy has been achieved.<\/p>\n\n\n\n
How to Choose the Right Investigation Without Confusing Screening and Diagnosis<\/strong><\/h2>\n\n\n\nOne of the most frequent mistakes is to view all genetic tests during pregnancy as having the same medical value. In reality, the difference between \u201crisk estimation\u201d and \u201cdiagnostic confirmation\u201d completely changes the way a result should be interpreted. A low-risk screening result does not absolutely exclude every condition, and a high-risk screening result does not automatically mean there is a certain diagnosis.<\/p>\n\n\n\n
That is why the correct choice begins with a few simple questions: what exactly is being looked for, what can the test show, what can it not show, and what follows after the result. In some cases, the answer is sufficiently covered by screening and ultrasound. In other situations, the doctor may recommend additional investigations or diagnostic testing. What matters is that the decision is made in an informed way, without pressure, and with a clear understanding of the limits of each method.<\/p>\n\n\n\n
Frequently Asked Questions<\/strong><\/h2>\n\n\n\nAre genetic tests during pregnancy mandatory?<\/strong>
No. These investigations are part of prenatal monitoring options and are recommended depending on the clinical context. The decision is made together with the doctor, after you understand the benefits, limitations, and what information each test can provide.<\/p>\n\n\n\nWhat is the difference between NIPT and amniocentesis?<\/strong>
NIPT is a screening test performed from maternal blood and estimates the risk for certain chromosomal abnormalities. Amniocentesis is an invasive diagnostic test, performed after 15 weeks, which can more clearly confirm certain abnormalities.<\/p>\n\n\n\nFrom how many weeks can genetic tests during pregnancy be done?<\/strong>
Some screening tests can be performed starting from around 10 weeks, while CVS is usually carried out between 11 weeks and 13 weeks plus 6 days. Amniocentesis is generally recommended after 15 weeks.<\/p>\n\n\n\nDoes a good screening result exclude every genetic problem?<\/strong>
Not completely. A low-risk result reduces the probability of certain investigated conditions, but it does not exclude all genetic conditions or all fetal development problems.<\/p>\n\n\n\nWhen is amniocentesis recommended?<\/strong>
Amniocentesis may be recommended when there is a high-risk screening result, an ultrasound suspicion, or family or obstetric history that justifies diagnostic testing.<\/p>\n\n\n\nIf the pregnancy was achieved through In Vitro Fertilization, are genetic tests during pregnancy still useful?<\/strong>
Yes, they may still be useful, depending on medical history and the doctor\u2019s recommendation. Preimplantation testing and prenatal monitoring serve different roles and should not be confused.<\/p>\n\n\n\nIs carrier screening the same thing as fetal testing?<\/strong>
No. Carrier screening refers to the parents and shows whether they are carriers of genes associated with certain inherited diseases. Prenatal fetal testing looks for a different type of information and is used at a different stage.<\/p>\n\n\n\nHow should the results be interpreted correctly?<\/strong>
Results should always be interpreted in the clinical context, together with the obstetrician and, when needed, the medical geneticist. An isolated result without correlation with ultrasound and medical history can lead to incorrect conclusions.<\/p>\n\n\n\n\n
\n Andreas Vythoulkas<\/p>\n
Specialty Placeholder<\/p>\n <\/div>\n <\/div>\n <\/div>\n\n
\n <\/div>\n \n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\nWhen Genetic Tests During Pregnancy Are Recommended<\/strong><\/h2>\n\n\n\nNot all patients need the same testing plan. In general, the doctor may recommend genetic tests during pregnancy in several well-defined situations:<\/p>\n\n\n\n
\n- when the results of previous screening suggest a higher risk<\/li>\n\n\n\n
- when ultrasound raises suspicion of a fetal abnormality<\/li>\n\n\n\n
- when there is a family history of genetic disease<\/li>\n\n\n\n
- when there has been a previous pregnancy affected by a genetic or chromosomal abnormality<\/li>\n\n\n\n
- when there are maternal or paternal risk factors that justify further evaluation<\/li>\n<\/ul>\n\n\n\n
It is important to know that advanced maternal age may influence recommendations, but it is not the only criterion. In many cases, the indication for genetic tests during pregnancy appears after correlating several elements: medical history, ultrasound, biochemical results, and the discussion about family history. That is why testing should not be understood as a formality, but as part of a careful medical monitoring process.<\/p>\n\n\n\n
For patients who achieved pregnancy after assisted reproduction treatment, the frequent question arises whether prenatal testing is still necessary. The answer depends on the context. Even if procedures such as aneuploidy screening (PGT-A) or embryo biopsy were used before embryo transfer, these do not automatically replace all pregnancy monitoring recommendations. PGT-A belongs to the preimplantation stage, while genetic tests during pregnancy refer to prenatal monitoring after pregnancy has been achieved.<\/p>\n\n\n\n
How to Choose the Right Investigation Without Confusing Screening and Diagnosis<\/strong><\/h2>\n\n\n\nOne of the most frequent mistakes is to view all genetic tests during pregnancy as having the same medical value. In reality, the difference between \u201crisk estimation\u201d and \u201cdiagnostic confirmation\u201d completely changes the way a result should be interpreted. A low-risk screening result does not absolutely exclude every condition, and a high-risk screening result does not automatically mean there is a certain diagnosis.<\/p>\n\n\n\n
That is why the correct choice begins with a few simple questions: what exactly is being looked for, what can the test show, what can it not show, and what follows after the result. In some cases, the answer is sufficiently covered by screening and ultrasound. In other situations, the doctor may recommend additional investigations or diagnostic testing. What matters is that the decision is made in an informed way, without pressure, and with a clear understanding of the limits of each method.<\/p>\n\n\n\n
Frequently Asked Questions<\/strong><\/h2>\n\n\n\nAre genetic tests during pregnancy mandatory?<\/strong>
No. These investigations are part of prenatal monitoring options and are recommended depending on the clinical context. The decision is made together with the doctor, after you understand the benefits, limitations, and what information each test can provide.<\/p>\n\n\n\nWhat is the difference between NIPT and amniocentesis?<\/strong>
NIPT is a screening test performed from maternal blood and estimates the risk for certain chromosomal abnormalities. Amniocentesis is an invasive diagnostic test, performed after 15 weeks, which can more clearly confirm certain abnormalities.<\/p>\n\n\n\nFrom how many weeks can genetic tests during pregnancy be done?<\/strong>
Some screening tests can be performed starting from around 10 weeks, while CVS is usually carried out between 11 weeks and 13 weeks plus 6 days. Amniocentesis is generally recommended after 15 weeks.<\/p>\n\n\n\nDoes a good screening result exclude every genetic problem?<\/strong>
Not completely. A low-risk result reduces the probability of certain investigated conditions, but it does not exclude all genetic conditions or all fetal development problems.<\/p>\n\n\n\nWhen is amniocentesis recommended?<\/strong>
Amniocentesis may be recommended when there is a high-risk screening result, an ultrasound suspicion, or family or obstetric history that justifies diagnostic testing.<\/p>\n\n\n\nIf the pregnancy was achieved through In Vitro Fertilization, are genetic tests during pregnancy still useful?<\/strong>
Yes, they may still be useful, depending on medical history and the doctor\u2019s recommendation. Preimplantation testing and prenatal monitoring serve different roles and should not be confused.<\/p>\n\n\n\nIs carrier screening the same thing as fetal testing?<\/strong>
No. Carrier screening refers to the parents and shows whether they are carriers of genes associated with certain inherited diseases. Prenatal fetal testing looks for a different type of information and is used at a different stage.<\/p>\n\n\n\nHow should the results be interpreted correctly?<\/strong>
Results should always be interpreted in the clinical context, together with the obstetrician and, when needed, the medical geneticist. An isolated result without correlation with ultrasound and medical history can lead to incorrect conclusions.<\/p>\n\n\n\n\n
It is important to know that advanced maternal age may influence recommendations, but it is not the only criterion. In many cases, the indication for genetic tests during pregnancy appears after correlating several elements: medical history, ultrasound, biochemical results, and the discussion about family history. That is why testing should not be understood as a formality, but as part of a careful medical monitoring process.<\/p>\n\n\n\n
For patients who achieved pregnancy after assisted reproduction treatment, the frequent question arises whether prenatal testing is still necessary. The answer depends on the context. Even if procedures such as aneuploidy screening (PGT-A) or embryo biopsy were used before embryo transfer, these do not automatically replace all pregnancy monitoring recommendations. PGT-A belongs to the preimplantation stage, while genetic tests during pregnancy refer to prenatal monitoring after pregnancy has been achieved.<\/p>\n\n\n\n
How to Choose the Right Investigation Without Confusing Screening and Diagnosis<\/strong><\/h2>\n\n\n\nOne of the most frequent mistakes is to view all genetic tests during pregnancy as having the same medical value. In reality, the difference between \u201crisk estimation\u201d and \u201cdiagnostic confirmation\u201d completely changes the way a result should be interpreted. A low-risk screening result does not absolutely exclude every condition, and a high-risk screening result does not automatically mean there is a certain diagnosis.<\/p>\n\n\n\n
That is why the correct choice begins with a few simple questions: what exactly is being looked for, what can the test show, what can it not show, and what follows after the result. In some cases, the answer is sufficiently covered by screening and ultrasound. In other situations, the doctor may recommend additional investigations or diagnostic testing. What matters is that the decision is made in an informed way, without pressure, and with a clear understanding of the limits of each method.<\/p>\n\n\n\n
Frequently Asked Questions<\/strong><\/h2>\n\n\n\nAre genetic tests during pregnancy mandatory?<\/strong>
No. These investigations are part of prenatal monitoring options and are recommended depending on the clinical context. The decision is made together with the doctor, after you understand the benefits, limitations, and what information each test can provide.<\/p>\n\n\n\nWhat is the difference between NIPT and amniocentesis?<\/strong>
NIPT is a screening test performed from maternal blood and estimates the risk for certain chromosomal abnormalities. Amniocentesis is an invasive diagnostic test, performed after 15 weeks, which can more clearly confirm certain abnormalities.<\/p>\n\n\n\nFrom how many weeks can genetic tests during pregnancy be done?<\/strong>
Some screening tests can be performed starting from around 10 weeks, while CVS is usually carried out between 11 weeks and 13 weeks plus 6 days. Amniocentesis is generally recommended after 15 weeks.<\/p>\n\n\n\nDoes a good screening result exclude every genetic problem?<\/strong>
Not completely. A low-risk result reduces the probability of certain investigated conditions, but it does not exclude all genetic conditions or all fetal development problems.<\/p>\n\n\n\nWhen is amniocentesis recommended?<\/strong>
Amniocentesis may be recommended when there is a high-risk screening result, an ultrasound suspicion, or family or obstetric history that justifies diagnostic testing.<\/p>\n\n\n\nIf the pregnancy was achieved through In Vitro Fertilization, are genetic tests during pregnancy still useful?<\/strong>
Yes, they may still be useful, depending on medical history and the doctor\u2019s recommendation. Preimplantation testing and prenatal monitoring serve different roles and should not be confused.<\/p>\n\n\n\nIs carrier screening the same thing as fetal testing?<\/strong>
No. Carrier screening refers to the parents and shows whether they are carriers of genes associated with certain inherited diseases. Prenatal fetal testing looks for a different type of information and is used at a different stage.<\/p>\n\n\n\nHow should the results be interpreted correctly?<\/strong>
Results should always be interpreted in the clinical context, together with the obstetrician and, when needed, the medical geneticist. An isolated result without correlation with ultrasound and medical history can lead to incorrect conclusions.<\/p>\n\n\n\n\n
Are genetic tests during pregnancy mandatory?<\/strong> What is the difference between NIPT and amniocentesis?<\/strong> From how many weeks can genetic tests during pregnancy be done?<\/strong> Does a good screening result exclude every genetic problem?<\/strong> When is amniocentesis recommended?<\/strong> If the pregnancy was achieved through In Vitro Fertilization, are genetic tests during pregnancy still useful?<\/strong> Is carrier screening the same thing as fetal testing?<\/strong> How should the results be interpreted correctly?<\/strong>
No. These investigations are part of prenatal monitoring options and are recommended depending on the clinical context. The decision is made together with the doctor, after you understand the benefits, limitations, and what information each test can provide.<\/p>\n\n\n\n
NIPT is a screening test performed from maternal blood and estimates the risk for certain chromosomal abnormalities. Amniocentesis is an invasive diagnostic test, performed after 15 weeks, which can more clearly confirm certain abnormalities.<\/p>\n\n\n\n
Some screening tests can be performed starting from around 10 weeks, while CVS is usually carried out between 11 weeks and 13 weeks plus 6 days. Amniocentesis is generally recommended after 15 weeks.<\/p>\n\n\n\n
Not completely. A low-risk result reduces the probability of certain investigated conditions, but it does not exclude all genetic conditions or all fetal development problems.<\/p>\n\n\n\n
Amniocentesis may be recommended when there is a high-risk screening result, an ultrasound suspicion, or family or obstetric history that justifies diagnostic testing.<\/p>\n\n\n\n
Yes, they may still be useful, depending on medical history and the doctor\u2019s recommendation. Preimplantation testing and prenatal monitoring serve different roles and should not be confused.<\/p>\n\n\n\n
No. Carrier screening refers to the parents and shows whether they are carriers of genes associated with certain inherited diseases. Prenatal fetal testing looks for a different type of information and is used at a different stage.<\/p>\n\n\n\n
Results should always be interpreted in the clinical context, together with the obstetrician and, when needed, the medical geneticist. An isolated result without correlation with ultrasound and medical history can lead to incorrect conclusions.<\/p>\n\n\n\n\n